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 19 
Abstract 20 
Since its initial discovery in an Escherichia coli isolate from China, mcr-1 has also been 21 
detected in Klebsiella pneumoniae and Salmonella enterica, and is rarely reported in 22 
other Enterobacteriaceae. Here, we report the isolation and identiﬁcation of a Shigella 23 
flexneri strain harboring mcr-1 from stool samples in a pig farm in China from 2009. The 24 
minimum inhibitory concentration (MIC) to colistin of the isolate is 4 µg/mL. Conjugation 25 
assays showed the donor S. flexneri strain has functional and transferable colistin 26 
resistance. Sequencing revealed that mcr-1 was present on a putative composite 27 
transposon flanked by inverted repeats of ISApl1. 28 
Importance 29 
There are four species of Shigella, Shigella flexneri is the most frequently isolated species 30 
in Low and Middle Income Countries (LMICs). In this study, we report a functional, 31 
transferable, plasmid mediated mcr-1 in S. flexneri. We have shown mcr-1 is located on a 32 
novel composite transposon which is flanked by inverted repeats of ISApl1. The host 33 
strain is multi-drug resistant and this multidrug resistance is also transferable. The finding 34 
of functional mcr-1 in S. flexneri; a human associated Enterobacteriaceae is a cause for 35 
concern as infections due to S. flexneri are the main Shigella infections in most Low and 36 
Middle Income Countries.  37 
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transposon  39 
Introduction 40 
Antimicrobial resistance is a major global health issue and is on the national and 41 
international agenda of all United Nations member states and many organizations 42 
including the World Health Organization (1). Decreased susceptibility to the most 43 
widely used antibiotics, including ampicillin, streptomycin, 44 
trimethoprim/sulfamethoxazole, and tetracycline for enteric pathogens has become a 45 
major concern, especially in Low and Middle Income Countries (LMICs) (2, 3). 46 
Following the emergence of metallo-beta-lactamases, including NDM-1 and extended 47 
spectrum beta-lactamases such as the CTX-M group in the Enterobacteriaceae, 48 
carbapenems and third-generation cephalosporins can no longer be relied upon as 49 
treatments for infections caused by multidrug-resistant Enterobacteriaceae (4, 5). For 50 
this reason, the polymyxins (colistin and polymyxin B) have become a last resort 51 
antibiotic (6) and were reclassified as critically important for human medicine by the 52 
WHO in 2011 (7).  53 
Since the first report of transferable, plasmid-mediated colistin resistance 54 
conferred by mcr-1 (8), researchers in different countries have found that many 55 
Enterobacteriaceae carry mcr-1 (9-13). The origin of mcr-1 positive strains are varied. 56 
Agricultural establishments, retail meat and patients with infections are three major 57 
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sources of colistin resistant bacteria. Since its initial discovery in an Escherichia coli 58 
isolate from China, mcr-1 has been detected in Southeast Asia, Europe, America and 59 
Africa (14-17). Most of the mcr-1 positive strains are E. coli, Klebsiella pneumoniae 60 
and Salmonella enterica, whilst the gene is rarely reported in other 61 
Enterobacteriaceae. A recent report described the presence of a mcr-1-positive 62 
Shigella sonnei from Vietnam, however a colistin resistance phenotype was only 63 
observed following transfer to E. coli (18).  64 
Shigella spp. are recognized as etiological agents of diarrhea and have been 65 
responsible for serious worldwide epidemics (19). Shigella flexneri is the most 66 
frequently isolated species in many countries and is responsible for approximately 10% 67 
of all diarrheal episodes in children younger than five years (20). S. flexneri 3a is also 68 
commonly isolated in male homosexuals in the US (21) and the UK (22). Between 69 
2004 and 2015, S. flexneri strains were isolated and collected in China. By screening 70 
available isolate collections via PCR, we identified a single mcr-1 positive strain of S. 71 
flexneri. 72 
 73 
Results 74 
Bacterial strains and mcr-1 screening  75 
A total of 2127 S. flexneri were isolated from the samples collected from thirteen 76 
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different areas in China; these were Beijing, Shenyang, Shandong, Henan, Anhui, 77 
Hubei, Xinjiang, Gansu, Sichuan, Guizhou, Yunnan, Guangxi and Guangdong 78 
province. There are fifteen different serotypes among the S. flexneri strains. Most of 79 
the strains were isolated from stool samples of patients who were suffering from 80 
clinically diagnosed gastroenteritis, a small number of strains (< 10%) were isolated 81 
from farm and urban environments. Through the PCR screening for the presence of 82 
mcr-1 amongst all the S. flexneri strains, only one mcr-1 positive isolate, named C960 83 
was found. The serotype of the positive isolate is y and it was isolated from pig stool 84 
samples in a pig farm in Guangxi province in 2009.  85 
Antimicrobial susceptibility and PCR ampliﬁcation of resistance genes 86 
Antimicrobial susceptibility tests showed that, besides colistin, S. flexneri C960 was 87 
resistant to tetracycline, ticarcillin, ampicillin, trimethoprim/ sulfamethoxazole, 88 
sulfafurazole and streptomycin (Table 1). Through PCR we found that strain C960 89 
carried other acquired resistance genes including qnrS1, blaTEM-1, dfrA14 and strB, 90 
which could confer decreased susceptibility to quinolones, β-lactam antibiotics, 91 
trimethoprim and streptomycin respectively.  92 
Plasmid DNA sequencing and analysis  93 
After sequencing and assembly of the plasmids of S. flexneri C960, analysis showed 94 
that mcr-1 in C960 was located on a 65538 bp plasmid designated pRC960-2. The 95 
plasmid has a GC content of 43.2%, contains 92 predicted open reading frames 96 
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(ORFs) and has a typical IncI2 plasmid backbone (57756 bp) encoding replication, 97 
conjugation apparatus and stability functions (Fig 1). The pRC960-2 plasmid 98 
sequence (GenBank accession number KY784668) was highly similar（Query cover 99 
95%, Identity 99%）to that of pHNSHP45 (GenBank accession number KP347127) (8) 100 
and pABC149-MCR-1 (from E. coli strain ABC149 isolated from the Arabian 101 
Peninsula in a clinical blood sample in 2013. GenBank accession number KX013538) 102 
(15). Apart from mcr-1, there is no other identifiable resistance gene in pRC960-2 103 
(Fig 1). Compared with the first described mcr-1 plasmid, pHNSHP45, the region 104 
around mcr-1 in plasmid pRC960-2 had one SNP in the region upstream of mcr-1 105 
(Fig 2 A). Additionally, there are inverted copies of ISApl1 flanking mcr-1 and some 106 
other ISs in plasmid pRC960-2 compared with pHNSHP45 and the other two 107 
homologous plasmids (Fig 2 B). Except for the inverted repeat of ISApl1, the other 108 
genes around mcr-1 were identical to those in plasmid pABC149-MCR-1, plasmid 109 
pEG430-1 (from S. sonnei. strain EG430, isolated in a hospital in Vietnam in 2008. 110 
GenBank accession number LT174530) and pHNSHP45 (Fig 3). Compared with the 111 
plasmid pEG430-1; which carries an inactive mcr-1 in Shigella sonnei, there is no 22 112 
bp duplication in mcr-1 (in pRC960-2) which has been previously reported to be 113 
responsible for inactivity (18). Other detected resistance, or resistance-associated 114 
genes including qnrS1, blaTEM-1, dfrA14 and IntI1 were located on a different plasmid 115 
without mcr-1. This plasmid; pRC960-1 has a length of 75 kb (GenBank accession 116 
number KY848295). Through BLAST, the plasmid which contains other resistance 117 
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genes aligned closely with E. coli strain PGRT46 plasmid pPGRT46 found in Nigeria 118 
(Fig S1). 119 
Conjugation assays  120 
In order to determine if the plasmids could be transferred, we performed conjugation 121 
experiments of S. flexneri C960 with E. coli J53 as the recipient strain. The E. coli 122 
J53 transconjugant, was found to be resistant to colistin (MIC 4 mg/L) the same as the 123 
donor. The MIC to other antimicrobials also increased and the E. coli J53 recipient 124 
had almost the same antimicrobial susceptibilities as the donor (Table 1).  We 125 
detected mcr-1, qnrS1, blaTEM-1, dfrA14 and strB gene in the transconjugant by PCR. 126 
This suggests that both plasmids from the S. flexneri C960 transferred into E. coli J53 127 
recipient and explains the increase in resistance phenotypes observed.  128 
Excision of Tn6390  129 
We found there is an inverted copy of ISApl1 flanking mcr-1, which is unusual 130 
as copies of ISApl1 are usually directly repeated as in Tn6330 (23, 24). This putative 131 
composite transposon was re-amplified by PCR and the PCR products were 132 
sequenced to ensure that it was not an artifact due to sequence mis-assembly of the 133 
plasmid reads. The putative composite transposon (>ISApl1-mcr-1-orf-ISApl1<) was 134 
given the designation Tn6390 by the Transposon Registry (25). We used primers 135 
MCR1-RC-F and MCR1-R (19) to test the ability of Tn6390 to generate a circular 136 
intermediate molecule. Through this pair of reverse primers we got a 1598bp 137 
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fragment which contains an intact PAP2 and parts of mcr-1. The putative structure of 138 
Tn6390 showed in Fig 4 B. Then we used primers IS-2 and IS-6 in order to detect the 139 
structure formed by two ISApl1. The 1293 bp PCR product (Fig 4 C and D) amplified 140 
by IS-2 and IS-6 was the intact ISApl1 and a part of nikB (located in the downstream 141 
of mcr-1). The sequences of PCR products were conﬁrmed by Sanger sequencing. 142 
Discussion 143 
Among the four species of Shigella, S. flexneri is the most frequently isolated species 144 
in LMICs. Humans are the primary reservoir of Shigella spp.(26) which is different 145 
from Salmonella spp. and E. coli, which are more widely distributed in the 146 
environment. Isolation of plasmid-mediated colistin resistance in S. flexneri from 147 
animal faeces on a farm suggests it is circulating via the faecal – oral route at least 148 
amongst the animals on that farm and possibly further afield via the food distribution 149 
network. In addition, it suggests that farm environments may be an unrecognized 150 
reservoir of S. flexneri.  151 
The use of colistin in Chinese agriculture has been enormous and sustained. 152 
Between 2470 – 2875 metric tons have been used in the growth of food-producing 153 
animals annually in last 5 years (27). Because of the varied and uncontrolled drug 154 
administration techniques (injection, added to feed and water) in food-animal rearing, 155 
the selective pressures are high enough to suggest that a large proportion of drug 156 
resistance emerged from the agriculture sector. This use has allowed for the selection, 157 
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transfer and maintenance of plasmid mediated colistin resistance into clinical strains 158 
of E. coli, K. pneumoniae and Salmonella spp. and rarely into other 159 
Enterobacteriaceae. With such a sustained selective pressure and transferable 160 
resistance circulating amongst these strains it is unlikely that this will be the only 161 
Shigella flexneri strain containing transferable colistin resistance in a farm 162 
environment. Also, as only a small number of strains (< 10%) were isolated from 163 
farm and urban environments, we were surprised to find 1 with mcr-1 on a 164 
transferable plasmid which is a relatively high frequency of detection compared to the 165 
clinical strains.  166 
Worryingly, not only did colistin resistance transfer during the filter mating but 167 
also a host of mobile elements including integron, IS and other resistance genes 168 
which are present on the other plasmid transferred. This suggests that under the 169 
selective pressure of colistin, other plasmids conferring multi-drug resistant 170 
phenotypes can be acquired from the S. flexneri strain. The integron and IS could also 171 
help the strain to obtain other resistance from environment. China have banned 172 
colistin as an animal feed additive recently (28), however the phenomenon of other 173 
inappropriate prophylactic antimicrobial use in farms could still inadvertently select 174 
for multiple resistance phenotypes including co-located colistin resistance.  175 
A novel transposon Tn6390 is found in S. flexneri C960 in which two inverted 176 
copies of ISApl1 ﬂank mcr-1. ISApl1 plays a pivotal role in the transposition of mcr-1 177 
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(24, 29) however, almost all other reported structures formed by 178 
ISApl1-mcr-1-orf-ISApl1 have two direct repeats of ISApl1 (23, 24, 30). There is a 179 
1293bp PCR product consisting of intact ISApl1 and a part of nikB which was 180 
presumably the result of a hairpin conformation within the plasmid (Fig 4 B). The 181 
consequences on intra and intercellular mobility of the inverted orientation of ISApl1 182 
are currently under investigation.  183 
Overall, our research shows that a functional and transferable mcr-1 exists in a 184 
multidrug resistant S. flexneri strain isolated from an agricultural environment. 185 
Considering the mcr-1 strain was from a small number of agriculturally sourced 186 
Shigella and the changing epidemiology of Shigella spp. infections, surveillance of 187 
mcr-1 in both environmental and clinical isolates would be advised. 188 
Materials and methods 189 
Strains and mcr-1 screening  190 
During the period of 2004 to 2015, a total of 2127 S. flexneri strains were 191 
isolated as part of the national pathogen monitoring system in China. These strains 192 
were identiﬁed by standard microbiological techniques and then stored in glycerol 193 
stocks at -80C. Colonies were serologically confirmed by slide agglutination with 194 
appropriate group-specific polyvalent antisera, followed by type-specific monovalent 195 
antisera (Denka Seikan, Tokyo, Japan). Basic epidemiological data (date and region 196 
of isolation, sex and age of patient) were recorded for each isolate. We retrospectively 197 
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investigated presence of mcr-1 by PCR screening the historical S. flexneri isolates by 198 
using the previously published primers (8) CLR5-F 199 
(5’-CGGTCAGTCCGTTTGTTC-3’) and CLR5-R 200 
(5ʹ-CTTGGTCGGTCTGTAGGG-3ʹ).  201 
Antimicrobial susceptibility testing  202 
The susceptibility of 28 antimicrobials (Ceftazidime, Ceftiofur, Ceftriaxone, 203 
Cefepime, Cefoperazone, Cefazolin, Cefoxitin, Imipenem, Azithromycin, 204 
Nitrofurantoin, Piperacillin, Ampicillin, Amoxicillin/Clavulanic acid, Ticarcillin, 205 
Tetracycline, Tobramycin, Gentamicin, Amikacin, Aztreonam, Streptomycin, 206 
Chloramphenicol, Timentin, Trimethoprim/ Sulfamethoxazole, Sulfafurazole, 207 
Nalidixan, Ciprofloxacin, Levofloxacin, Norfloxacin) of the S. flexneri C960, 208 
recipient E. coli J53 and the E. coli J53 transconjugants were determined by the broth 209 
microdilution using a 96-well microtiter plate (Sensititre, Trek Diagnostic Systems, 210 
Thermo Fisher Scientific Inc). The susceptibility of colistin and polymyxin B were 211 
determined by Microbial Viability Assay Kit-WST (Dojindo Molecular Technologies 212 
Inc, Japan). A reference strain of E. coli (ATCC 25922) was included in the test as a 213 
quality control. Interpretation of antimicrobial minimal inhibitory concentrations 214 
(MICs) was performed according to the Clinical and Laboratory Standards Institute 215 
(CLSI, 2017) criteria.  216 
PCR ampliﬁcation of resistance genes  217 
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DNA samples were prepared using a TIANamp Bacteria DNA Kit (Tiangen, 218 
Beijing) following the manufacturer’s recommendations. Reactions were performed 219 
with 2.5 U of Taq DNA Polymerase (Takara, Japan) according to the manufacturer’s 220 
recommendation. The ampliﬁcation reaction, conducted in a Techne thermo cycler 221 
(Bio-Red), consisted of initial denaturation at 94°C for 5 mins followed by 30 cycles 222 
at 94°C for 30 s, 55°C for 30 s and 72°C for 1 min. A ﬁnal elongation step ran at 72°C 223 
for 10 min. PCR amplicons were fully sequenced. Other antibiotic resistance 224 
determinants were detected by PCR using the primers listed in Table 2. The sequences 225 
were analyzed using tools located at the NCBI and aligned to the sequences in 226 
GenBank. 227 
Plasmid DNA sequencing and analysis  228 
Plasmid DNA of the S. flexneri C960 was extracted using a Qiagen Plasmid Midi 229 
kit (Qiagen, Germany). The DNA was used to construct a 600-bp insert library using 230 
NEBNext Ultra II DNA Library Prep Kit (NEB, Singapore). Then sequenced by 231 
MiSeq Reagent Kit v3 using MiSeq platform (Illumina, CA, USA). Raw reads were 232 
first assembled into contigs using Newbler version 3.0, followed by gap filling by 233 
local assembly. S1-PFGE and Southern blot were used to determine the length of the 234 
plasmids. To ensure accuracy, the raw reads were mapped onto the assembled 235 
complete genomes to detect the mis-assembly and low quality regions. In order to get 236 
complete plasmid sequences, the gaps were filled through combinatorial PCR and 237 
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Sanger sequencing on an ABI 3730 Sequencer (LifeTechn query ologies, CA, USA). 238 
The detection and typing of the plasmids were found using PlasmidFinder 239 
(https://cge.cbs.dtu.dk/services/PlasmidFinder/). Each assembled genome was 240 
annotated with the Rapid Annotations using Subsystems Technology (RAST) server 241 
and verified with the Basic Local Alignment Search Tool (BLAST) against the 242 
non-redundant NCBI database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Annotation of 243 
resistance genes, mobile elements and other genetic structures was based on the 244 
relevant databases including CARD, BacMet, β-lactamases Database and ISfinder. 245 
Plasmids pHNSHP45 (GenBank accession number KP347127), pABC149-MCR-1 246 
(GenBank accession number KX013538), pEG430-1(GenBank accession number 247 
LT174530), and pPGRT46 (GenBank accession number KM023153) were used as the 248 
reference plasmids for annotation. Plasmid maps were prepared using DNAplotter 249 
and Circos. The Tn number was designated by the Transposon Registry (25). The 250 
complete sequences of pRC960-1 and pRC960-2 was submitted to GenBank under 251 
accession number KY848295 and KY784668, respectively. Raw data of S. flexneri 252 
C960 has been uploaded to NCBI Sequence Read Archive (SRA) under accession 253 
number SRP130733. 254 
Conjugation assays  255 
The ability of mcr-1 to undergo horizontal gene transfer was assessed by broth 256 
and filter-mating using a standard E. coli J53 azide-resistant strain as the 257 
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recipient. The donor/recipient ratio was 10:1 and the temperature was 30°C. 258 
MacConkey agar containing 100 mg/L sodium azide and 2 mg/L colistin was used to 259 
select for E. coli J53 transconjugants. Both SS agar and XLD media (BD Difco, USA) 260 
with 2 mg/L colistin were chosen to select for E. coli J53 transconjugants. Putative 261 
transconjugants were confirmed by antimicrobial susceptibility testing and detection 262 
of mcr-1 with PCR and sequencing. No spontaneous resistance to azide could be 263 
detected in the S. flexneri donor. 264 
Detection of the circular structure carried mcr-1  265 
To test the stability of the Tn6330-like structure, primers were designed to detect 266 
the circular structure consisted of ISApl1-mcr-1-orf-ISApl1 (Table 3). The locations 267 
of the primers are shown in Fig S2. The PCR amplicons were fully sequenced. 268 
Accession number(s) 269 
The sequences determined in this study have been deposited in GenBank under 270 
the accession numbers KY784668 and KY848295. All sequencing data from this 271 
study is available through the NCBI Sequence Read Archive (SRA) under accession 272 
number SRP130733. 273 
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 382 
 383 
 384 
 385 
 386 
Figure 1. 387 
Structure of plasmid pRC960-2 carrying mcr-1 from Shigella flexneri strain C960. Genes are 388 
denoted by arrows and colored based on gene function classification. The innermost circle present 389 
GC contents. The second circle presents GC-Skew [(G − C)/(G + C)].  390 
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 391 
 392 
Figure 2.  393 
Comparison of the surrounding structure of mcr-1 in four similar plasmids pHNSHP45, 394 
pABC149-MCR-1, pEG430-1 and pRC960-2. Compared with other three plasmids, an additional, 395 
inverted repeat of ISApl1 is present downstream of mcr-1 in plasmid pRC960-2. A single SNP 396 
upstream of mcr-1 (-36) changes from T to C in plasmid pRC960-2. 397 
 398 
 399 
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 400 
Figure 3.  401 
Comparison of the circular genome map of plasmid sequences of three plasmids genome 402 
structures with pHNSHP45 sequence as reference genome. The green circles from inside to 403 
outside are pRC960-2, pEG430-1, pABC149-MCR-1 and pHNSHP45 plasmid sequences, 404 
respectively, with respect to the reference pHNSHP45 plasmid genome. In pRC960-2, there is an 405 
inverted copy of ISApl1 flanking mcr-1. A 22 bp duplication of bases 503–525 of mcr-1 ORF is 406 
found in plasmid pEG430-1. The single SNP in the upstream of mcr-1 in pRC960-2, 407 
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pABC149-MCR-1, pEG430-1 are the same. 408 
 409 
 410 
 411 
Figure 4. 412 
(A) The linear structure of mcr-1 surrounding genes, the arrows stand for the locations of the 413 
primers used to detect the circular structure. (B) The presumable structure in plasmid pRC960-2 414 
of S. flexneri strain C960. (C) The sequencing result of the PCR products generated by primers 415 
IS-2 and IS-6. (D) Gel picture of the 1293bp PCR products generated by primers IS-2 and IS-6 416 
targeting surrounding sequences of Tn6390. The amplicon of this pair of primers is consist of 417 
parts of nikB and a complete ISApl1. (E) Schematic representation of the presumable circular 418 
structure including mcr-1.  419 
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 420 
Table 1. Antimicrobial susceptibility results of S. flexneri C960, E. coli J53 and transconjugant. 421 
 C960 J53 Transconjugant 
Colistin  4µg/mL R <=0.2µg/mL S 4µg/mL R 
Polymyxin B  4µg/mL R <=0.2µg/mL S 4µg/mL R 
Tetracycline >8 µg/mL R <=4µg/mL S >32µg/mL R 
Ticarcillin >64µg/mL R <=16µg/mL S >64µg/mL R 
Ampicillin >16µg/mL R <=8µg/mL S >32µg/mL R 
Trimethoprim/ sulfamethoxazole >2µg/mL R <=2µg/mL S >4µg/mL R 
Sulfafurazole >256µg/mL R <=16µg/mL S >256µg/mL R 
Streptomycin >64µg/mL R <=2µg/mL S >64µg/mL R 
Cefazolin <=8µg/mL S <=8µg/mL S <=8µg/mL S 
Cefoxitin <=8µg/mL S <=8µg/mL S <=8µg/mL S 
Ceftazidime  <=1µg/mL S <=1µg/mL S <=1µg/mL S 
Ceftriaxone  <=1µg/mL S <=1µg/mL S <=1µg/mL S 
Cefoperazone <=16µg/mL S <=16µg/mL S <=16µg/mL S 
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Ceftiofur <=0.12µg/mL S <=0.5µg/mL S <=0.5µg/mL S 
Cefepime <=8µg/mL S <=8µg/mL S <=8µg/mL S 
Piperacillin <=16µg/mL S <=16µg/mL S <=16µg/mL S 
Amoxicillin/Clavulanic acid <=4µg/mL S <=4µg/mL S <=8µg/mL S 
Timentin <=16µg/mL S <=16µg/mL S <=16µg/mL S 
Aztreonam <=1µg/mL S <=1µg/mL S <=1µg/mL S 
Imipenem  <=4µg/mL S <=4µg/mL S <=4µg/mL S 
Nalidixan <=4µg/mL S <=4µg/mL S <=8µg/mL S 
Ciprofloxacin <=0.25µg/mL S <=0.015µg/mL S <=0.5µg/mL S 
Norfloxacin <=4µg/mL S <=4µg/mL S <=4µg/mL S 
Levofloxacin <=2µg/mL S <=2µg/mL S <=2µg/mL S 
Tobramycin <=4µg/mL S <=4µg/mL S <=4µg/mL S 
Gentamicin <=4µg/mL S <=4µg/mL S <=4µg/mL S 
Amikacin <=16µg/mL S <=16µg/mL S <=16µg/mL S 
Chloramphenicol <=8µg/mL S <=8µg/mL S <=8µg/mL S 
Nitrofurantoin <=32µg/mL S <=32µg/mL S <=32µg/mL S 
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Azithromycin <=2µg/mL S <=4µg/mL S <=4µg/mL S 
(S: Sensitive, R: Resistance.) 422 
 423 
Table 2. Primers used in PCR amplification of antibiotic resistance genes 424 
Primers Nucleotide sequence (5’ to 3’) Target Length (bp) Reference 
β-lactamases  
blaCTX-M-1 group-F 
blaCTX-M-1 group-R 
GGTTAAAAAATCACTGCGTC 
TTACAAACCGTCGGTGACGA 
blaCTX-M 1 group 873 This study 
blaCTX-M-9 group-F 
blaCTX-M-9 group-R 
AGAGTGCAACGGATGATG 
CCAGTTACAGCCCTTCGG 
blaCTX-M 9 group 868 This study 
blaCTX-M-2/8/25 group-F 
blaCTX-M-2/8/25 group-R 
ACCGAGCCSACGCTCAA 
CCGCTGCCGGTTTTATC 
blaCTX-M-2/8/25 
group 
221 This study 
blaTEM-F 
blaTEM-R 
ATGAGTATTCAACATTTCCG 
CCAATGCTTAATCAGTGAGG 
blaTEM 1080 (31) 
blaOXA-F 
blaOXA-R 
ATTAAGCCCTTTACCAAACCA 
AAGGGTTGGGCGATTTTGCCA 
blaOXA 890 (19) 
 o
n
 M
arch 14, 2018 by LIVERPO
O
L SCH O
F TRO
PICAL M
ED
http://aem
.asm
.org/
D
ow
nloaded from
 
blaVIM-F3 
blaVIM-R3 
AGTGGTGAGTATCCGACAG 
ATGAAAGTGCGTGGAGAC 
blaVIM 509 (32) 
blaNDM-1-F 
blaNDM-1-R 
GTCTGGCAGCACACTTCCTA 
TAGTGCTCAGTGTCGGCATC 
blaNDM-1 515 This study 
Integrons  
IntI1-F2 
IntI1-R2 
ACATGTGATGGCGACGCACGA 
ATTTCTGTCCTGGCTGGCGA 
IntI1 569 (33) 
IntI2-F3 
IntI2-R3 
CACGGATATGCGACAAAAAGGT 
GTAGCAAACGAGTGACGAAATG 
IntI2 789 (33) 
hep58 
hep59 
TCATGGCTTGTTATGACTGT 
GTAGGGCTTATTATGCACGC 
Class 1 integron 
variable region 
variable This study 
hep74 
 
hep51 
CGGGATCCCGGACGGCATGCACGA
TTTGTA 
GATGCCATCGCAAGTACGAG 
Class 2 integron 
variable region 
variable (19) 
Chromosomal mutations-mediated quinolone resistance  
gyrA-F TACACCGGTCAACATTGAGG gyrA 648 (34) 
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gyrA-R TTAATGATTGCCGCCGTCGG 
gyrB-F 
gyrB-R 
TGAAATGACCCGCCGTAAAGG 
GCTGTGATAACGCAGTTTGTCCGGG 
gyrB 309 (34) 
parC-F 
parC-R 
GTACGTGATCATGGACCGTG 
TTCGGCTGGTCGATTAATGC 
parC 531 (34) 
parE-F 
parE-R 
ATGCGTGCGGCTAAAAAAGTG 
TCGTCGCTGTCAGGATCGATAC 
parE 290 (34) 
Plasmid-mediated quinolone resistance  
qnrA-F3 
qnrA-R3 
ATTTCTCACGCCAGGATTTG 
GATCGGCAAAGGTYAGGTCA 
qnrA 516 (35) 
qnrB-F 
qnrB-R 
GATCGTGAAAGCCAGAAAGG 
ACGAYGCCTGGTAGTTGTCC 
qnrB 469 (35) 
qnrD-F 
qnrD-R 
CGAGATCAATTTACGGGGAATA 
AACAAGCTGAAGCGCCTG 
qnrD 656 (31) 
qnrS-F 
qnrS-R 
ACGACATTCGTCAACTGCAA 
TAAATTGGCACCCTGTAGGC 
qnrS 417 (35) 
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 425 
 426 
Table 3. Primers used in PCR amplification to confirm the >ISApl1-mcr-1-ISApl1< 427 
arrangement 428 
aac(6')-Ib-cr-F 
aac(6')-Ib-cr-R 
GCAACGCAAAAACAAAGTTAGG 
GTGTTTGAACCATGTACA 
aac(6')-Ib-cr 560 (36) 
Primers Nucleotide sequence (5’ to 3’) Target Length (bp) Reference 
IS-1:  
IS-4 
TACTTCCTACCGCCATCTTACA  
TACTTCCTACCGACATCTTAC  
The whole length of Tn6390 4537 This study 
MCR1-RC-F  
MCR1-R 
CTTGGTCGGTCTGTAGGG 
TGTCCACGGTTGATGCG 
To test the ability of Tn6390 
to generate circular 
intermediate 
1598 (23) 
IS-5  
IS-7 
TCTGTTTGGGGTTGATT 
 AAAGTCAAAGACCGCACC 
ISApl1 and HP1 in the 
upstream of mcr-1 
1904 This study 
IS-2  
IS-6 
GAGCCATACGGTGGTGT 
CGAATCCGATTTGCTTA 
The intact ISApl1 and a part 
of nikB 
1293 This study 
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 429 
IS-8 CACAAGAACAAACGGACTGAC ISApl1 in the downstream of 
mcr-1 and a part of mcr-1 
 This study 
IS-a AACGCCTACTGGCTGAGATGAG To sequence Tn6390  This study 
IS-b GGTCGCAACCAGCAAG To sequence Tn6390  This study 
IS-c GTGGCGTTCAGCAGTCATT To sequence Tn6390  This study 
IS-d GCTTACCCACCGAGTAGATT To sequence Tn6390  This study 
IS-e TGGTCGCTGATTGGTTTT To sequence Tn6390  This study 
IS-f GACACCACCGTATGGCTCA To sequence Tn6390  This study 
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